To further confirm whether inhibiting necroptosis is capable of ameliorating depression, we will explore whether GSK872, a RIPK3 inhibitor, ameliorates the depressive-like behavior of CUMS-exposed rats. This evidence concerns the gene RIPK3 and major depressive disorder.